Literature DB >> 11375406

VCAM-1 is critical in atherosclerosis.

K Ley1, Y Huo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11375406      PMCID： PMC209304          DOI： 10.1172/JCI13005

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  21 in total

1.  Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions.

Authors:  Y Huo; A Hafezi-Moghadam; K Ley
Journal:  Circ Res       Date:  2000-07-21       Impact factor: 17.367

2.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.

Authors:  M I Cybulsky; K Iiyama; H Li; S Zhu; M Chen; M Iiyama; V Davis; J C Gutierrez-Ramos; P W Connelly; D S Milstone
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice.

Authors:  C L Ramos; Y Huo; U Jung; S Ghosh; D R Manka; I J Sarembock; K Ley
Journal:  Circ Res       Date:  1999-06-11       Impact factor: 17.367

4.  Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of apolipoprotein-E-deficient mice.

Authors:  D R Manka; P Wiegman; S Din; J M Sanders; S A Green; L W Gimple; M Ragosta; E R Powers; K Ley; I J Sarembock
Journal:  J Vasc Res       Date:  1999 Sep-Oct       Impact factor: 1.934

5.  Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice.

Authors:  S Oguchi; P Dimayuga; J Zhu; K Y Chyu; J Yano; P K Shah; J Nilsson; B Cercek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-07       Impact factor: 8.311

6.  Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice.

Authors:  Z M Dong; A A Brown; D D Wagner
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

7.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes.

Authors:  L Osborn; C Hession; R Tizard; C Vassallo; S Luhowskyj; G Chi-Rosso; R Lobb
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

8.  P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice.

Authors:  R G Collins; R Velji; N V Guevara; M J Hicks; L Chan; A L Beaudet
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

9.  Neonatally induced inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune response.

Authors:  C E Leuker; M Labow; W Müller; N Wagner
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

10.  Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow.

Authors:  P A Koni; S K Joshi; U A Temann; D Olson; L Burkly; R A Flavell
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307
View more
  63 in total

1.  Autoantibodies and thrombophilia in RA: TNFalpha and TNFalpha blockers.

Authors:  G F Ferraccioli; E Gremese
Journal:  Ann Rheum Dis       Date:  2004-03-17       Impact factor: 19.103

Review 2.  MicroRNA in ischemic stroke etiology and pathology.

Authors:  Cameron Rink; Savita Khanna
Journal:  Physiol Genomics       Date:  2010-09-14       Impact factor: 3.107

3.  LFA-1 and Mac-1 define characteristically different intralumenal crawling and emigration patterns for monocytes and neutrophils in situ.

Authors:  Ronen Sumagin; Hen Prizant; Elena Lomakina; Richard E Waugh; Ingrid H Sarelius
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

4.  Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction.

Authors:  Mourad Zerfaoui; Yasuhiro Suzuki; Amarjit S Naura; Chetan P Hans; Charles Nichols; A Hamid Boulares
Journal:  Cell Signal       Date:  2007-10-12       Impact factor: 4.315

Review 5.  Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis.

Authors:  Khosrow Khodabandehlou; Jacqueline J Masehi-Lano; Christopher Poon; Jonathan Wang; Eun Ji Chung
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

6.  Urinary albumin excretion is increased in patients with rheumatoid arthritis and associated with arterial stiffness.

Authors:  Karima Becetti; Annette Oeser; Michelle J Ormseth; Joseph F Solus; Paolo Raggi; C Michael Stein; Cecilia P Chung
Journal:  J Rheumatol       Date:  2015-02-01       Impact factor: 4.666

7.  ABCA1 Overexpression in Endothelial Cells In Vitro Enhances ApoAI-Mediated Cholesterol Efflux and Decreases Inflammation.

Authors:  Alexis Stamatikos; Nagadhara Dronadula; Philip Ng; Donna Palmer; Ethan Knight; Bradley K Wacker; Chongren Tang; Francis Kim; David A Dichek
Journal:  Hum Gene Ther       Date:  2018-10-02       Impact factor: 5.695

8.  Prolonged Mechanical Circumferential Stretch Induces Metabolic Changes in Rat Inferior Vena Cava.

Authors:  M A Anwar; P A Vorkas; J Li; K N Adesina-Georgiadis; O M Reslan; J D Raffetto; E J Want; R A Khalil; E Holmes; A H Davies
Journal:  Eur J Vasc Endovasc Surg       Date:  2016-08-11       Impact factor: 7.069

9.  Expanded network of inflammatory markers of atherogenesis: where are we now?

Authors:  Seyed Hesameddin Abbasi; Mohammad Ali Boroumand
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

10.  In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences.

Authors:  Julien Dimastromatteo; Alexis Broisat; Pascale Perret; Mitra Ahmadi; Didier Boturyn; Pascal Dumy; Daniel Fagret; Laurent M Riou; Catherine Ghezzi
Journal:  J Nucl Med       Date:  2013-05-29       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.